Use of Freeze-thawed Embryos for High-efficiency Production of Genetically Modified Mice.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
02 04 2020
Historique:
entrez: 21 4 2020
pubmed: 21 4 2020
medline: 24 9 2020
Statut: epublish

Résumé

The use of genetically modified (GM) mice has become crucial for understanding gene function and deciphering the underlying mechanisms of human diseases. The CRISPR/Cas9 system allows researchers to modify the genome with unprecedented efficiency, fidelity, and simplicity. Harnessing this technology, researchers are seeking a rapid, efficient, and easy protocol for generating GM mice. Here we introduce an improved method for cryopreservation of one-cell embryos that leads to a higher developmental rate of the freeze-thawed embryos. By combining it with optimized electroporation conditions, this protocol allows for the generation of knockout and knock-in mice with high efficiency and low mosaic rates within a short time. Furthermore, we show a step-by-step explanation of our optimized protocol, covering CRISPR reagent preparation, in vitro fertilization, cryopreservation and thawing of one-cell embryos, electroporation of CRISPR reagents, mouse generation, and genotyping of the founders. Using this protocol, researchers should be able to prepare GM mice with unparalleled ease, speed, and efficiency.

Identifiants

pubmed: 32310226
doi: 10.3791/60808
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Hirofumi Nishizono (H)

Max Planck Florida Institute for Neuroscience; Life Science Research Center, University of Toyama; Department of Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University; hirofumi.nishizono@mpfi.org.

Mohamed Darwish (M)

Graduate School of Innovative Life Science, University of Toyama; Department of Biochemistry, Faculty of Pharmacy, Cairo University.

Hideki Uosaki (H)

Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University; Division of Stem Cell Research and Drug Development, Center for Development of Advanced Medical Technology, Jichi Medical University.

Nanami Masuyama (N)

Synthetic Biology Division, Research Center for Advanced Science and Technology, University of Tokyo; Institute for Advanced Biosciences, Keio University; Graduate School of Media and Governance, Keio University.

Motoaki Seki (M)

Synthetic Biology Division, Research Center for Advanced Science and Technology, University of Tokyo; Department of Molecular Oncology, Graduate School of Medicine, Chiba University.

Hiroyuki Abe (H)

Department of Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University.

Nozomu Yachie (N)

Synthetic Biology Division, Research Center for Advanced Science and Technology, University of Tokyo; Institute for Advanced Biosciences, Keio University; Graduate School of Media and Governance, Keio University; Department of Biological Sciences, School of Science, University of Tokyo; College of Arts and Sciences, University of Tokyo.

Ryohei Yasuda (R)

Max Planck Florida Institute for Neuroscience.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH